Advertisement
Journal Home
Search for

Issue

Alert me when new journal issues are available via Request TOC Alert via emailor via Request RSS feed of current issue

previous issue next issue

Cancer Treatment Reviews
Volume 31, Issue 7, Pages 507-590 (November 2005)
Search Within This Issue

display abstract citation download email a colleague
Display:


Editorial board
page CO2
Full-Text PDF (228 KB)

TUMOUR REVIEWS


Cystic neoplasms of the pancreas; What a clinician should know, 02 November 2005
George H. Sakorafas, Michael G. Sarr
pages 507-535
Abstract | Full Text | Full-Text PDF (878 KB)


Renal cell carcinoma: Current status and future prospects, 17 October 2005
Beverly J. Drucker
pages 536-545
Abstract | Full Text | Full-Text PDF (157 KB)

COMPLICATIONS OF TREATMENT


Preventing radiation induced xerostomia, 02 November 2005
Michael I. Koukourakis, Vassilios Danielidis
pages 546-554
Abstract | Full Text | Full-Text PDF (141 KB)


Radiation recall: A well recognized but neglected phenomenon, 19 September 2005
David Azria, Nicolas Magné, Abderrahim Zouhair, Pierre Castadot, Stéphane Culine, Marc Ychou, Roger Stupp, Paul Van Houtte, Jean-Bernard Dubois, Mahmut Ozsahin
pages 555-570
Abstract | Full Text | Full-Text PDF (168 KB)

EVIDENCE BASED ONCOLOGY


Gemcitabine plus docetaxel for advanced or metastatic non-small cell lung cancer: Similar survival to cisplatin plus vinorelbine and less toxicity: Abstracted from: Pujol JL, Breton JL, Gervais R, et al. Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin. Ann Oncol 2005;16:602–10., 19 October 2005
Benjamin Solomon, Paul A. Bunn
pages 571-576
Full Text | Full-Text PDF (98 KB)


Adding temozolomide to radiotherapy prolongs survival in people with glioblastoma: Abstracted from: Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987–96., 19 October 2005
Alba A. Brandes
pages 577-581
Full Text | Full-Text PDF (76 KB)


Radiotherapy plus adjuvant goserelin improves survival in men with poor prognosis prostate cancer: Abstracted from: Pilepich MV, Winter K, Lawton CA, et al. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma: long-term results of Phase III RTOG 85-31. Int J Radiat Oncol Biol Phys 2005; 61:1285–90., 02 November 2005
Mack Roach
pages 582-586
Full Text | Full-Text PDF (86 KB)


High-quality evidence in oncology from 14 April to 12 May 2005: A summary, 24 October 2005
Liz Bickerdike, Ben Djulbegovic
pages 587-589
Full Text | Full-Text PDF (56 KB)

display abstract citation download email a colleague
Display:
Advertisement